Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,576
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Durham NC,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase1, Phase2, Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: St. John's, Gloucester MA, Beverly MA, Burlington MA,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase3, Recruiting
Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
for
Keratoconus, Corneal Ectasia
Location: Hoffman Estates IL
Sponsor: Robert Mack, M.D.
Sex: All
Age: 18 - 70+
Code: NCT02009709
Phase1, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Boston MA, Horsham PA, Philadelphia PA, Richmond VA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Location: Lebanon NH, The Bronx NY, New York NY, Durham NC,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50+
Code: NCT06455085
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Halifax, New Haven CT, Westbury NY, Columbia MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase3, Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
for
Parkinson's Disease
Location: Boston MA, Farmington CT, New York NY, Philadelphia PA,
Sponsor: Parkinson's Foundation
Sex: All
Age: 18+
Code: NCT04994015
Recruiting
StrokeNet Thrombectomy Endovascular Platform
for
Ischemic Stroke
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06289985
Recruiting
Telehealth Implementation of Brain-Computer Interface
for
Amyotrophic Lateral Sclerosis, Stroke
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 16 - 70+
Code: NCT05951556
Recruiting
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
for
Breast Cancer
Location: Chicago IL, La Jolla CA, Sacramento CA
Sponsor: University of Chicago
Sex: Female
Age: 25+
Code: NCT03729115
Recruiting
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
for
Hypogonadism, Male
Location: Boston MA, Worcester MA, The Bronx NY, Philadelphia PA,
Sponsor: Halozyme Therapeutics
Sex: Male
Age: 12 - 17
Code: NCT06689085
Phase3, Recruiting
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
for
Aortic Aneurysm, Abdominal
Location: Stony Brook NY, New Brunswick NJ, Hershey PA,
Sponsor: Rijnstate Hospital
Sex: All
Age: 18+
Code: NCT05484115
Recruiting
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: New York NY, Fort Lee NJ, Lake City FL, Birmingham AL,
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Summit NJ, Montreal,